These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6892350)

  • 1. [Effect of dopamine intracerebrally injected by the Valzelli method on methamphetamine-stereotypy and hypermotility].
    Nomura Y; Ashikari S; Naganuma K; Sakuma K; Watanabe M; Kobayashi M
    Yakubutsu Seishin Kodo; 1982 Jul; 2(1):25-37. PubMed ID: 6892350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Methamphetamine-stereotypy and hypermotility" in rats chronically treated with reserpine--the effect of intracerebral injection of chlorpromazine].
    Sano H; Totsuka Y; Furuuchi T; Sakai K; Koshikawa N; Shigehara R; Kobayashi M
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):113-24. PubMed ID: 6890928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of alpha-methyl-para-tyrosine on "methamphetamine-induced sterotype and hypermotility" of reserpinized rats (author's transl)].
    Nakajima H; Shigehara R; Shimada M; Totsuka Y; Arai E; Kobayashi M
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):557-69. PubMed ID: 7199507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Methamphetamine-stereotypies" and brain dopamine levels of rats treated with single or repeated doses of alpha-methyl-para-tyrosine (author's transl)].
    Kobayashi M; Wakamatsu Y; Shinohara M; Teraoka Y; Koshikawa N
    Nihon Yakurigaku Zasshi; 1977 Sep; 73(6):695-701. PubMed ID: 562821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
    Yamaguchi K; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin in ephedrine-induced stereotypy and hypermotility.
    Malec D; Langwiński R; Kruszewska A
    Arch Immunol Ther Exp (Warsz); 1976; 24(6):829-36. PubMed ID: 138404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
    Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A; Havemann-Reinecke U
    J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
    Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
    Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of some 5-HT receptors in methamphetamine-induced locomotor activity in mice.
    Ginawi OT; Al-Majed AA; Al-Suwailem AK; El-Hadiyah TM
    J Physiol Pharmacol; 2004 Jun; 55(2):357-69. PubMed ID: 15213358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modification of stereotypy-producing and ambulation-increasing effects following repeated administration of methamphetamine in rats].
    Kifune A; Tadokoro S
    Yakubutsu Seishin Kodo; 1991 Jun; 11(3):207-14. PubMed ID: 1771975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
    Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
    Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central action of glaucine in rodents.
    Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
    Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
    Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.